United States Software & IT Services

Certara Inc (CERT)

Track

Track

Certara Inc. witnessed a single insider transaction over the past ninety days, involving a proposed sale of shares by officer Leif E. Pedersen valued at approximately 300,069 USD. This activity follows recent volatility in the company's stock price, which has risen 33.7% recently despite a negative earnings report miss last August.
Ticker: CERT Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Certara Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Pedersen Leif E Officer Officer
Transaction date
Proposed sale
Price
464.75
Quantity 26,104
Value US$2,028,832
1.5
Feehery William F CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Purchase
Price
322.69
Quantity 2,596 +11.7%
Value US$4,266,854
Pedersen Leif E PRESIDENT, CHIEF COMMERCAL OFF Officer
Transaction date
Planned sale
Price
144.74
Quantity 60,829 -2.3%
Value US$4,099,613
Pedersen Leif E Officer Officer
Transaction date
Proposed sale
Price
10.92
Quantity 51,224
Value US$559,304
SMITH PATRICK F Officer Officer
Transaction date
Proposed sale
Price
9.73
Quantity 20,142
Value US$195,982
SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS Officer
Transaction date
Planned sale
Price
11.03
Quantity 5,409 -9.7%
Value US$59,661
SMITH PATRICK F Officer Officer
Transaction date
Proposed sale
Price
11.03
Quantity 5,409
Value US$59,661
Pedersen Leif E PRESIDENT, CHIEF COMMERCAL OFF Officer
Transaction date
Planned sale
Price
11.29
Quantity 51,224 -33.9%
Value US$578,319
Pedersen Leif E Officer Officer
Transaction date
Proposed sale
Price
11.29
Quantity 51,224
Value US$578,450
SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS Officer
Transaction date
Planned sale
Price
17.77
Quantity 422 -0.8%
Value US$7,499
SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS Officer
Transaction date
Planned sale
Price
16.77
Quantity 4,740 -8.6%
Value US$79,490
SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS Officer
Transaction date
Planned sale
Price
17.67
Quantity 328 -0.6%
Value US$5,796
SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS Officer
Transaction date
Planned sale
Price
16.75
Quantity 3,024 -5.2%
Value US$50,652
SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS Officer
Transaction date
Planned sale
Price
17.72
Quantity 649 -1.1%
Value US$11,500
SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS Officer
Transaction date
Planned sale
Price
16.76
Quantity 5,264 -8.2%
Value US$88,225
SMITH PATRICK F Officer Officer
Transaction date
Proposed sale
Price
17.62
Quantity 14,427
Value US$254,204
Traynor Richard M. SVP AND GENERAL COUNSEL Officer
Transaction date
Planned sale
Price
18.00
Quantity 3,000 -1.7%
Value US$54,000
Traynor Richard M. Officer Officer
Transaction date
Proposed sale
Price
18.00
Quantity 3,000
Value US$54,000
Traynor Richard M. SVP AND GENERAL COUNSEL Officer
Transaction date
Planned sale
Price
18.28
Quantity 3,000 -1.8%
Value US$54,840
Traynor Richard M. Officer Officer
Transaction date
Proposed sale
Price
18.28
Quantity 3,000
Value US$54,840
SMITH PATRICK F PRESIDENT, DRUG DEV SOLUTIONS Officer
Transaction date
Planned sale
Price
18.00
Quantity 5,000 -8.3%
Value US$90,000
SMITH PATRICK F Officer Officer
Transaction date
Proposed sale
Price
18.00
Quantity 5,000
Value US$90,000
Traynor Richard M. SVP AND GENERAL COUNSEL Officer
Transaction date
Planned sale
Price
18.00
Quantity 6,000 -3.5%
Value US$108,000
Traynor Richard M. Officer Officer
Transaction date
Proposed sale
Price
18.00
Quantity 6,000
Value US$108,000
Traynor Richard M. SVP AND GENERAL COUNSEL Officer
Transaction date
Planned sale
Price
18.00
Quantity 6,000 -3.4%
Value US$108,000
Traynor Richard M. Officer Officer
Transaction date
Proposed sale
Price
18.00
Quantity 6,000
Value US$108,000
Pedersen Leif E PRESIDENT, CHIEF COMMERCAL OFF Officer
Transaction date
Planned sale
Price
14.60
Quantity 51,224 -28.4%
Value US$747,870
Pedersen Leif E Officer Officer
Transaction date
Proposed sale
Price
14.60
Quantity 51,224
Value US$748,065
1.7
BROSHY ERAN Non-Executive Director
Transaction date
Purchase
Price
15.80
Quantity 4,807 +50.3%
Value US$75,951
1.7
BROSHY ERAN Non-Executive Director
Transaction date
Purchase
Price
16.10
Quantity 193 +2.1%
Value US$3,107
SMITH PATRICK F PRESIDENT, INTEGRATED DRUG DEV Officer
Transaction date
Planned sale
Price
21.55
Quantity 19,104 -24.2%
Value US$411,691
SMITH PATRICK F Officer Officer
Transaction date
Proposed sale
Price
21.55
Quantity 19,104
Value US$411,691
Traynor Richard M. SVP AND GENERAL COUNSEL Officer
Transaction date
Planned sale
Price
20.82
Quantity 5,000 -2.7%
Value US$104,100
Traynor Richard M. Officer Officer
Transaction date
Proposed sale
Price
20.82
Quantity 5,000
Value US$104,100
Traynor Richard M. SVP AND GENERAL COUNSEL Officer
Transaction date
Planned sale
Price
23.66
Quantity 5,000 -2.7%
Value US$118,300
Traynor Richard M. Officer Officer
Transaction date
Proposed sale
Price
23.66
Quantity 5,000
Value US$118,300
Traynor Richard M. SVP AND GENERAL COUNSEL Officer
Transaction date
Planned sale
Price
21.45
Quantity 10,000 -5.1%
Value US$214,500
Traynor Richard M. Officer Officer
Transaction date
Proposed sale
Price
21.45
Quantity 10,000
Value US$214,500
Traynor Richard M. SVP AND GENERAL COUNSEL Officer
Transaction date
Planned sale
Price
20.00
Quantity 15,000 -7.2%
Value US$300,000
2.6
EQT Avatar Parent L.P. Large shareholder
Transaction date
Sale
Price
15.00
Quantity 29,954,521 -100.0%
Value US$449,317,815
Pedersen Leif E PRESIDENT, SOFTWARE Officer
Transaction date
Planned sale
Price
15.55
Quantity 51,223 -22.6%
Value US$796,518
3.3
SLAINE MASON P Non-Executive Director
Transaction date
Sale
Price
15.57
Quantity 245,793 -27.1%
Value US$3,826,997
3.3
SLAINE MASON P Non-Executive Director
Transaction date
Sale
Price
15.27
Quantity 4,207 -0.5%
Value US$64,241
1.8
WALSH MATTHEW M Non-Executive Director
Transaction date
Sale
Price
14.74
Quantity 12,059 -6.7%
Value US$177,750
SMITH PATRICK F PRESIDENT, INTEGRATED DRUG DEV Officer
Transaction date
Planned sale
Price
13.48
Quantity 2,387 -3.1%
Value US$32,177
0.8
McLean Stephen M. Non-Executive Director
Transaction date
Purchase
Price
16.32
Quantity 20,000 +90.9%
Value US$326,400
0.9
Schemick Michael Andrew CHIEF FINANCIAL OFFICER Officer
Transaction date
Purchase
Price
16.64
Quantity 25,000 +5.1%
Value US$416,000
SMITH PATRICK F PRESIDENT, INTEGRATED DRUG DEV Officer
Transaction date
Planned sale
Price
17.71
Quantity 10,000 -11.3%
Value US$177,100
3.3
SLAINE MASON P Non-Executive Director
Transaction date
Sale
Price
17.38
Quantity 182,475 -16.7%
Value US$3,171,416
2.6
EQT Avatar Parent L.P. Large shareholder
Transaction date
Sale
Price
17.38
Quantity 6,004,418 -16.7%
Value US$104,356,785
SMITH PATRICK F PRESIDENT, INTEGRATED DRUG DEV Officer
Transaction date
Planned sale
Price
19.16
Quantity 10,000 -10.2%
Value US$191,600
3.3
SLAINE MASON P Non-Executive Director
Transaction date
Sale
Price
19.52
Quantity 50,000 -4.4%
Value US$976,000
3.3
SLAINE MASON P Non-Executive Director
Transaction date
Sale
Price
19.59
Quantity 100,000 -8.0%
Value US$1,959,000
3.3
SLAINE MASON P Non-Executive Director
Transaction date
Sale
Price
19.55
Quantity 100,000 -7.4%
Value US$1,955,000
2.6
EQT Avatar Parent L.P. Large shareholder
Transaction date
Sale
Price
19.00
Quantity 1,500,000 -4.0%
Value US$28,500,000
SMITH PATRICK F PRESIDENT, INTEGRATED DRUG DEV Officer
Transaction date
Planned sale
Price
22.29
Quantity 3,352 -3.3%
Value US$74,716
3.3
SLAINE MASON P Non-Executive Director
Transaction date
Sale
Price
20.25
Quantity 125,000 -8.5%
Value US$2,531,250
3.3
SLAINE MASON P Non-Executive Director
Transaction date
Sale
Price
20.17
Quantity 125,000 -7.8%
Value US$2,521,250
Traynor Richard M. SVP AND GENERAL COUNSEL Officer
Transaction date
Planned sale
Price
20.00
Quantity 3,000 -1.4%
Value US$60,000
1.5
Feehery William F CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
20.17
Quantity 62,485 -2.8%
Value US$1,260,322
1.5
Feehery William F CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
20.29
Quantity 27,515 -1.2%
Value US$558,279
1.5
Feehery William F CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
23.93
Quantity 4,706 -0.2%
Value US$112,615
1.5
Feehery William F CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
23.31
Quantity 70,294 -3.0%
Value US$1,638,553
1.5
Feehery William F CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
25.49
Quantity 6,518 -0.3%
Value US$166,144
1.5
Feehery William F CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
24.93
Quantity 30,075 -1.3%
Value US$749,770
1.5
Feehery William F CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
23.83
Quantity 53,407 -2.2%
Value US$1,272,689
3.3
SLAINE MASON P Non-Executive Director
Transaction date
Planned sale
Price
26.80
Quantity 14,801 -0.9%
Value US$396,667
3.3
SLAINE MASON P Non-Executive Director
Transaction date
Planned sale
Price
26.53
Quantity 35,199 -2.1%
Value US$933,829
Traynor Richard M. SVP AND GENERAL COUNSEL Officer
Transaction date
Planned sale
Price
26.01
Quantity 3,000 -1.4%
Value US$78,030
1.5
Feehery William F CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
25.67
Quantity 51,196 -2.1%
Value US$1,314,201
1.5
Feehery William F CHIEF EXECUTIVE OFFICER Executive Director
Transaction date
Planned sale
Price
24.72
Quantity 23,804 -0.9%
Value US$588,435
Edge Justin PRES., REGULATORY & ACCESS Officer
Transaction date
Planned sale
Price
27.50
Quantity 5,000 -1.2%
Value US$137,500
Traynor Richard M. SVP AND GENERAL COUNSEL Officer
Transaction date
Planned sale
Price
27.44
Quantity 5,000 -2.2%
Value US$137,200
3.3
SLAINE MASON P Non-Executive Director
Transaction date
Planned sale
Price
28.88
Quantity 9,677 -0.6%
Value US$279,472
3.3
SLAINE MASON P Non-Executive Director
Transaction date
Planned sale
Price
28.57
Quantity 40,323 -2.4%
Value US$1,152,028
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-09-03 2026-09-03 PrS Proposed sale
Pedersen Leif E

Officer

Officer
26,104
464.75
US$2,028,832 		26,104 464.75 US$2,028,832
2025-11-12 2025-11-11 B Purchase
1.5
Feehery William F

CHIEF EXECUTIVE OFFICER

Executive Director
2,596 +11.7%
322.69
US$4,266,854 		2,596 +11.7% 322.69 US$4,266,854
2025-09-11 2025-09-09 PlS Planned sale
Pedersen Leif E

PRESIDENT, CHIEF COMMERCAL OFF

Officer
60,829 -2.3%
144.74
US$4,099,613 		60,829 -2.3% 144.74 US$4,099,613
2025-09-09 2025-09-09 PrS Proposed sale
Pedersen Leif E

Officer

Officer
51,224
10.92
US$559,304 		51,224 10.92 US$559,304
2025-04-02 2025-04-02 PrS Proposed sale
SMITH PATRICK F

Officer

Officer
20,142
9.73
US$195,982 		20,142 9.73 US$195,982
2024-10-08 2024-10-07 PlS Planned sale
SMITH PATRICK F

PRESIDENT, DRUG DEV SOLUTIONS

Officer
5,409 -9.7%
11.03
US$59,661 		5,409 -9.7% 11.03 US$59,661
2024-10-07 2024-10-07 PrS Proposed sale
SMITH PATRICK F

Officer

Officer
5,409
11.03
US$59,661 		5,409 11.03 US$59,661
2024-09-10 2024-09-09 PlS Planned sale
Pedersen Leif E

PRESIDENT, CHIEF COMMERCAL OFF

Officer
51,224 -33.9%
11.29
US$578,319 		51,224 -33.9% 11.29 US$578,319
2024-09-09 2024-09-09 PrS Proposed sale
Pedersen Leif E

Officer

Officer
51,224
11.29
US$578,450 		51,224 11.29 US$578,450
2024-04-04 2024-04-02 PlS Planned sale
SMITH PATRICK F

PRESIDENT, DRUG DEV SOLUTIONS

Officer
422 -0.8%
17.77
US$7,499 		422 -0.8% 17.77 US$7,499
2024-04-04 2024-04-02 PlS Planned sale
SMITH PATRICK F

PRESIDENT, DRUG DEV SOLUTIONS

Officer
4,740 -8.6%
16.77
US$79,490 		4,740 -8.6% 16.77 US$79,490
2024-04-04 2024-04-02 PlS Planned sale
SMITH PATRICK F

PRESIDENT, DRUG DEV SOLUTIONS

Officer
328 -0.6%
17.67
US$5,796 		328 -0.6% 17.67 US$5,796
2024-04-04 2024-04-02 PlS Planned sale
SMITH PATRICK F

PRESIDENT, DRUG DEV SOLUTIONS

Officer
3,024 -5.2%
16.75
US$50,652 		3,024 -5.2% 16.75 US$50,652
2024-04-04 2024-04-02 PlS Planned sale
SMITH PATRICK F

PRESIDENT, DRUG DEV SOLUTIONS

Officer
649 -1.1%
17.72
US$11,500 		649 -1.1% 17.72 US$11,500
2024-04-04 2024-04-02 PlS Planned sale
SMITH PATRICK F

PRESIDENT, DRUG DEV SOLUTIONS

Officer
5,264 -8.2%
16.76
US$88,225 		5,264 -8.2% 16.76 US$88,225
2024-04-02 2024-04-02 PrS Proposed sale
SMITH PATRICK F

Officer

Officer
14,427
17.62
US$254,204 		14,427 17.62 US$254,204
2024-04-03 2024-04-01 PlS Planned sale
Traynor Richard M.

SVP AND GENERAL COUNSEL

Officer
3,000 -1.7%
18.00
US$54,000 		3,000 -1.7% 18.00 US$54,000
2024-04-01 2024-04-01 PrS Proposed sale
Traynor Richard M.

Officer

Officer
3,000
18.00
US$54,000 		3,000 18.00 US$54,000
2024-03-05 2024-03-04 PlS Planned sale
Traynor Richard M.

SVP AND GENERAL COUNSEL

Officer
3,000 -1.8%
18.28
US$54,840 		3,000 -1.8% 18.28 US$54,840
2024-03-04 2024-03-04 PrS Proposed sale
Traynor Richard M.

Officer

Officer
3,000
18.28
US$54,840 		3,000 18.28 US$54,840
2024-02-21 2024-02-20 PlS Planned sale
SMITH PATRICK F

PRESIDENT, DRUG DEV SOLUTIONS

Officer
5,000 -8.3%
18.00
US$90,000 		5,000 -8.3% 18.00 US$90,000
2024-02-20 2024-02-20 PrS Proposed sale
SMITH PATRICK F

Officer

Officer
5,000
18.00
US$90,000 		5,000 18.00 US$90,000
2024-02-14 2024-02-12 PlS Planned sale
Traynor Richard M.

SVP AND GENERAL COUNSEL

Officer
6,000 -3.5%
18.00
US$108,000 		6,000 -3.5% 18.00 US$108,000
2024-02-12 2024-02-12 PrS Proposed sale
Traynor Richard M.

Officer

Officer
6,000
18.00
US$108,000 		6,000 18.00 US$108,000
2023-12-27 2023-12-26 PlS Planned sale
Traynor Richard M.

SVP AND GENERAL COUNSEL

Officer
6,000 -3.4%
18.00
US$108,000 		6,000 -3.4% 18.00 US$108,000
2023-12-26 2023-12-26 PrS Proposed sale
Traynor Richard M.

Officer

Officer
6,000
18.00
US$108,000 		6,000 18.00 US$108,000
2023-09-12 2023-09-11 PlS Planned sale
Pedersen Leif E

PRESIDENT, CHIEF COMMERCAL OFF

Officer
51,224 -28.4%
14.60
US$747,870 		51,224 -28.4% 14.60 US$747,870
2023-09-11 2023-09-11 PrS Proposed sale
Pedersen Leif E

Officer

Officer
51,224
14.60
US$748,065 		51,224 14.60 US$748,065
2023-08-23 2023-08-22 B Purchase
1.7
BROSHY ERAN
Non-Executive Director
4,807 +50.3%
15.80
US$75,951 		4,807 +50.3% 15.80 US$75,951
2023-08-23 2023-08-21 B Purchase
1.7
BROSHY ERAN
Non-Executive Director
193 +2.1%
16.10
US$3,107 		193 +2.1% 16.10 US$3,107
2023-06-06 2023-06-05 PlS Planned sale
SMITH PATRICK F

PRESIDENT, INTEGRATED DRUG DEV

Officer
19,104 -24.2%
21.55
US$411,691 		19,104 -24.2% 21.55 US$411,691
2023-06-05 2023-06-05 PrS Proposed sale
SMITH PATRICK F

Officer

Officer
19,104
21.55
US$411,691 		19,104 21.55 US$411,691
2023-05-15 2023-05-11 PlS Planned sale
Traynor Richard M.

SVP AND GENERAL COUNSEL

Officer
5,000 -2.7%
20.82
US$104,100 		5,000 -2.7% 20.82 US$104,100
2023-05-11 2023-05-11 PrS Proposed sale
Traynor Richard M.

Officer

Officer
5,000
20.82
US$104,100 		5,000 20.82 US$104,100
2023-04-17 2023-04-14 PlS Planned sale
Traynor Richard M.

SVP AND GENERAL COUNSEL

Officer
5,000 -2.7%
23.66
US$118,300 		5,000 -2.7% 23.66 US$118,300
2023-04-14 2023-04-14 PrS Proposed sale
Traynor Richard M.

Officer

Officer
5,000
23.66
US$118,300 		5,000 23.66 US$118,300
2023-03-07 2023-03-06 PlS Planned sale
Traynor Richard M.

SVP AND GENERAL COUNSEL

Officer
10,000 -5.1%
21.45
US$214,500 		10,000 -5.1% 21.45 US$214,500
2023-03-06 2023-03-06 PrS Proposed sale
Traynor Richard M.

Officer

Officer
10,000
21.45
US$214,500 		10,000 21.45 US$214,500
2023-02-03 2023-02-02 PlS Planned sale
Traynor Richard M.

SVP AND GENERAL COUNSEL

Officer
15,000 -7.2%
20.00
US$300,000 		15,000 -7.2% 20.00 US$300,000
2022-12-12 2022-12-08 S Sale
2.6
EQT Avatar Parent L.P.
Large shareholder
29,954,521 -100.0%
15.00
US$449,317,815 		29,954,521 -100.0% 15.00 US$449,317,815
2022-11-23 2022-11-22 PlS Planned sale
Pedersen Leif E

PRESIDENT, SOFTWARE

Officer
51,223 -22.6%
15.55
US$796,518 		51,223 -22.6% 15.55 US$796,518
2022-11-16 2022-11-15 S Sale
3.3
SLAINE MASON P
Non-Executive Director
245,793 -27.1%
15.57
US$3,826,997 		245,793 -27.1% 15.57 US$3,826,997
2022-11-16 2022-11-14 S Sale
3.3
SLAINE MASON P
Non-Executive Director
4,207 -0.5%
15.27
US$64,241 		4,207 -0.5% 15.27 US$64,241
2022-11-15 2022-11-14 S Sale
1.8
WALSH MATTHEW M
Non-Executive Director
12,059 -6.7%
14.74
US$177,750 		12,059 -6.7% 14.74 US$177,750
2022-11-14 2022-11-09 PlS Planned sale
SMITH PATRICK F

PRESIDENT, INTEGRATED DRUG DEV

Officer
2,387 -3.1%
13.48
US$32,177 		2,387 -3.1% 13.48 US$32,177
2022-08-23 2022-08-19 B Purchase
0.8
McLean Stephen M.
Non-Executive Director
20,000 +90.9%
16.32
US$326,400 		20,000 +90.9% 16.32 US$326,400
2022-08-18 2022-08-17 B Purchase
0.9
Schemick Michael Andrew

CHIEF FINANCIAL OFFICER

Officer
25,000 +5.1%
16.64
US$416,000 		25,000 +5.1% 16.64 US$416,000
2022-08-18 2022-08-16 PlS Planned sale
SMITH PATRICK F

PRESIDENT, INTEGRATED DRUG DEV

Officer
10,000 -11.3%
17.71
US$177,100 		10,000 -11.3% 17.71 US$177,100
2022-08-17 2022-08-16 S Sale
3.3
SLAINE MASON P
Non-Executive Director
182,475 -16.7%
17.38
US$3,171,416 		182,475 -16.7% 17.38 US$3,171,416
2022-08-17 2022-08-16 S Sale
2.6
EQT Avatar Parent L.P.
Large shareholder
6,004,418 -16.7%
17.38
US$104,356,785 		6,004,418 -16.7% 17.38 US$104,356,785
2022-06-09 2022-06-08 PlS Planned sale
SMITH PATRICK F

PRESIDENT, INTEGRATED DRUG DEV

Officer
10,000 -10.2%
19.16
US$191,600 		10,000 -10.2% 19.16 US$191,600
2022-06-03 2022-06-02 S Sale
3.3
SLAINE MASON P
Non-Executive Director
50,000 -4.4%
19.52
US$976,000 		50,000 -4.4% 19.52 US$976,000
2022-06-03 2022-06-02 S Sale
3.3
SLAINE MASON P
Non-Executive Director
100,000 -8.0%
19.59
US$1,959,000 		100,000 -8.0% 19.59 US$1,959,000
2022-06-03 2022-06-02 S Sale
3.3
SLAINE MASON P
Non-Executive Director
100,000 -7.4%
19.55
US$1,955,000 		100,000 -7.4% 19.55 US$1,955,000
2022-06-01 2022-05-31 S Sale
2.6
EQT Avatar Parent L.P.
Large shareholder
1,500,000 -4.0%
19.00
US$28,500,000 		1,500,000 -4.0% 19.00 US$28,500,000
2022-04-05 2022-04-04 PlS Planned sale
SMITH PATRICK F

PRESIDENT, INTEGRATED DRUG DEV

Officer
3,352 -3.3%
22.29
US$74,716 		3,352 -3.3% 22.29 US$74,716
2022-03-18 2022-03-17 S Sale
3.3
SLAINE MASON P
Non-Executive Director
125,000 -8.5%
20.25
US$2,531,250 		125,000 -8.5% 20.25 US$2,531,250
2022-03-18 2022-03-16 S Sale
3.3
SLAINE MASON P
Non-Executive Director
125,000 -7.8%
20.17
US$2,521,250 		125,000 -7.8% 20.17 US$2,521,250
2022-03-18 2022-03-16 PlS Planned sale
Traynor Richard M.

SVP AND GENERAL COUNSEL

Officer
3,000 -1.4%
20.00
US$60,000 		3,000 -1.4% 20.00 US$60,000
2022-03-17 2022-03-16 PlS Planned sale
1.5
Feehery William F

CHIEF EXECUTIVE OFFICER

Executive Director
62,485 -2.8%
20.17
US$1,260,322 		62,485 -2.8% 20.17 US$1,260,322
2022-03-14 2022-03-11 PlS Planned sale
1.5
Feehery William F

CHIEF EXECUTIVE OFFICER

Executive Director
27,515 -1.2%
20.29
US$558,279 		27,515 -1.2% 20.29 US$558,279
2022-02-22 2022-02-18 PlS Planned sale
1.5
Feehery William F

CHIEF EXECUTIVE OFFICER

Executive Director
4,706 -0.2%
23.93
US$112,615 		4,706 -0.2% 23.93 US$112,615
2022-02-22 2022-02-18 PlS Planned sale
1.5
Feehery William F

CHIEF EXECUTIVE OFFICER

Executive Director
70,294 -3.0%
23.31
US$1,638,553 		70,294 -3.0% 23.31 US$1,638,553
2022-02-22 2022-02-17 PlS Planned sale
1.5
Feehery William F

CHIEF EXECUTIVE OFFICER

Executive Director
6,518 -0.3%
25.49
US$166,144 		6,518 -0.3% 25.49 US$166,144
2022-02-22 2022-02-17 PlS Planned sale
1.5
Feehery William F

CHIEF EXECUTIVE OFFICER

Executive Director
30,075 -1.3%
24.93
US$749,770 		30,075 -1.3% 24.93 US$749,770
2022-02-22 2022-02-17 PlS Planned sale
1.5
Feehery William F

CHIEF EXECUTIVE OFFICER

Executive Director
53,407 -2.2%
23.83
US$1,272,689 		53,407 -2.2% 23.83 US$1,272,689
2022-02-02 2022-02-01 PlS Planned sale
3.3
SLAINE MASON P
Non-Executive Director
14,801 -0.9%
26.80
US$396,667 		14,801 -0.9% 26.80 US$396,667
2022-02-02 2022-02-01 PlS Planned sale
3.3
SLAINE MASON P
Non-Executive Director
35,199 -2.1%
26.53
US$933,829 		35,199 -2.1% 26.53 US$933,829
2022-01-27 2022-01-26 PlS Planned sale
Traynor Richard M.

SVP AND GENERAL COUNSEL

Officer
3,000 -1.4%
26.01
US$78,030 		3,000 -1.4% 26.01 US$78,030
2022-01-27 2022-01-26 PlS Planned sale
1.5
Feehery William F

CHIEF EXECUTIVE OFFICER

Executive Director
51,196 -2.1%
25.67
US$1,314,201 		51,196 -2.1% 25.67 US$1,314,201
2022-01-27 2022-01-26 PlS Planned sale
1.5
Feehery William F

CHIEF EXECUTIVE OFFICER

Executive Director
23,804 -0.9%
24.72
US$588,435 		23,804 -0.9% 24.72 US$588,435
2022-01-21 2022-01-20 PlS Planned sale
Edge Justin

PRES., REGULATORY & ACCESS

Officer
5,000 -1.2%
27.50
US$137,500 		5,000 -1.2% 27.50 US$137,500
2022-01-20 2022-01-18 PlS Planned sale
Traynor Richard M.

SVP AND GENERAL COUNSEL

Officer
5,000 -2.2%
27.44
US$137,200 		5,000 -2.2% 27.44 US$137,200
2022-01-04 2022-01-03 PlS Planned sale
3.3
SLAINE MASON P
Non-Executive Director
9,677 -0.6%
28.88
US$279,472 		9,677 -0.6% 28.88 US$279,472
2022-01-04 2022-01-03 PlS Planned sale
3.3
SLAINE MASON P
Non-Executive Director
40,323 -2.4%
28.57
US$1,152,028 		40,323 -2.4% 28.57 US$1,152,028
Explore more

More insider trading research around Certara Inc

More insider trades in United States
Similar Technology companies with insider activity
More Software & IT Services companies with insider activity
More Software & IT Services companies with insider activity
Insider trading in North America